DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Eryc (Erythromycin) - Reports of Side Effects & Adverse Reactions

 



This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Eryc (Erythromycin). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view all available reports.

Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.

All cases (11)
     Drug Interaction (6)Rhabdomyolysis (4)Drug Interaction Potentiation (3)more >>

Cases resulting in a serious event (11)
     Drug Interaction (6)Rhabdomyolysis (4)Drug Interaction Potentiation (3)more >>

Cases resulting in death (1)
     Rhabdomyolysis (1)Blood Phosphorus Increased (1)Drug Interaction (1)more >>

Cases resulting in hospitalization (6)
     Rhabdomyolysis (4)Drug Interaction (3)Weight Decreased (2)more >>

Cases resulting in other serious reactions (7)
     Drug Interaction (5)Drug Clearance Decreased (2)Rhabdomyolysis (2)more >>

Adverse event in 7 year old male receiving Eryc (Erythromycin)

Reported by a physician from France on 2007-07-09

Patient: 7 year old male

Adverse reactions / side effects: Drug Toxicity, Diplopia, Drug Interaction Potentiation, Coordination Abnormal

Adverse event resulted in: hospitalization

Suspect drug(s):
Eryc
    Dosage: oral
    Administration route: Oral
    Indication: Nasopharyngitis
    Start date: 1976-09-19
    End date: 1976-09-21

Eryc
    Dosage: oral
    Administration route: Oral
    Indication: Nasopharyngitis
    Start date: 1978-01-01
    End date: 1978-01-01

Eryc
    Dosage: oral
    Administration route: Oral
    Indication: Nasopharyngitis
    Start date: 1979-01-01
    End date: 1979-01-01

Carbamazepine
    Dosage: 800 mg daily, oral
    Administration route: Oral
    Indication: Epilepsy
    Start date: 1976-01-01

Phenobarbital(phenobarbital) 100mg
    Dosage: 100 mg daily, oral
    Administration route: Oral
    Indication: Epilepsy
    Start date: 1976-01-01

Phenyltoloxamine (Phenyltoloxamine)
    Indication: Nasopharyngitis
    Start date: 1976-09-01
    End date: 1976-09-01

Phenylpropanolamine HCL
    Indication: Nasopharyngitis
    Start date: 1976-09-01
    End date: 1976-09-01

Other drugs received by patient: Acetaminophen



Adverse event in 7 year old male receiving Eryc (Erythromycin)

Reported by a physician from France on 2007-07-09

Patient: 7 year old male

Adverse reactions / side effects: Diplopia, Drug Toxicity, Drug Interaction Potentiation, Coordination Abnormal, Somnolence

Adverse event resulted in: hospitalization

Suspect drug(s):
Eryc
    Dosage: see image
    Administration route: Oral
    Indication: Nasopharyngitis
    Start date: 1976-09-19
    End date: 1976-09-21

Eryc
    Dosage: see image
    Administration route: Oral
    Indication: Nasopharyngitis
    Start date: 1978-01-01
    End date: 1978-01-01

Eryc
    Dosage: see image
    Administration route: Oral
    Indication: Nasopharyngitis
    Start date: 1979-01-01
    End date: 1979-01-01

Carbamazepine (Carbamazepine) 800 MG
    Dosage: oral
    Administration route: Oral
    Indication: Epilepsy
    Start date: 1976-01-01

Phenobarbital(phenobarbital) 100mg
    Dosage: 100 mg daily, oral
    Administration route: Oral
    Indication: Epilepsy
    Start date: 1976-01-01

Phenyltoloxamine (Phenyltoloxamine)
    Indication: Nasopharyngitis
    Start date: 1976-09-01
    End date: 1976-09-01

Phenylpropanolamine HCL
    Indication: Nasopharyngitis
    Start date: 1976-09-01
    End date: 1976-09-01

Other drugs received by patient: Acetaminophen



Adverse event in 71 year old female receiving Eryc (Erythromycin)

Reported by a physician from United States on 2007-06-29

Patient: 71 year old female

Adverse reactions / side effects: Drug Interaction, Prothrombin Time Prolonged

Suspect drug(s):
Eryc
    Dosage: 1 g, oral
    Administration route: Oral

Warfarin Sodium



Adverse event in 71 year old female receiving Eryc (Erythromycin)

Reported by a physician from United States on 2007-06-28

Patient: 71 year old female

Adverse reactions / side effects: Vomiting, Nausea, Drug Interaction, Nodal Rhythm, Cardioactive Drug Level Increased

Suspect drug(s):
Eryc
    Dosage: 1 g over 24 hours; oral
    Administration route: Oral

Digoxin
    Dosage: 0.25 mg, qd; oral, qd
    Administration route: Oral



Adverse event in 83 year old male receiving Eryc (Erythromycin)

Reported by a physician from Norway on 2007-06-28

Patient: 83 year old male, weighing 102.0 kg (224.4 pounds)

Adverse reactions / side effects: Weight Decreased, Movement Disorder, Respiratory Disorder, Renal Impairment, Rhabdomyolysis, Creatinine Renal Clearance, Drug Interaction

Adverse event resulted in: hospitalization

Suspect drug(s):
Eryc
    Dosage: 500 mg, qid, oral
    Administration route: Oral
    Indication: Pneumonia Primary Atypical

Erythromycin
    Dosage: 50 mg, qid, intravenous
    Indication: Pneumonia Primary Atypical

Simvastatin
    Dosage: 80 mg, qd

Other drugs received by patient: Metoprolol Tartrate; Amlodipine; Hydrochlorothiazide W / Valsartan (Hydrochlorothiazide, Valsartan); Aspirin; Methotrexate; Furosemide



Adverse event in 40 year old female receiving Eryc (Erythromycin)

Reported by a physician from United States on 2007-06-28

Patient: 40 year old female

Adverse reactions / side effects: Drug Clearance Decreased, Drug Interaction Potentiation

Suspect drug(s):
Eryc
    Dosage: 2 gram qd; oral
    Administration route: Oral
    Indication: Respiratory Tract Infection

Theophylline
    Dosage: oral
    Administration route: Oral
    Indication: Asthma



Adverse event in 11 year old female receiving Eryc (Erythromycin)

Reported by a physician from United States on 2007-06-28

Patient: 11 year old female

Adverse reactions / side effects: Drug Clearance Decreased, Drug Interaction, Convulsion

Suspect drug(s):
Eryc
    Dosage: 250 mg, qid; oral
    Administration route: Oral
    Indication: Infection

Theophylline
    Dosage: 300 mg, tid; oral
    Administration route: Oral



Adverse event in 68 year old female receiving Eryc (Erythromycin)

Reported by a physician from United States on 2007-06-25

Patient: 68 year old female

Adverse reactions / side effects: Rhabdomyolysis, Blood Phosphorus Increased, Drug Interaction, Pyrexia, Idiopathic Pulmonary Fibrosis, Muscle Necrosis, Renal Failure, Ventricular Dysfunction, Mitral Valve Incompetence, Pulmonary Oedema, Aldolase Increased

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Eryc

Lovastatin
    Dosage: 20 mg, bid
    Indication: Hypercholesterolaemia

Other drugs received by patient: Ampicillin Sodium W / Sulbactam Sodium (Ampicillin Sodium, Sulbactam SOD; Amoxiclav / 01000301 / (Amoxicillin, Clavulanate Potassium); Furosemide; Sucralfate; Ranitidine; Allopurinol; Insulin (Insulin); Isosorbide (Isosorbide); Enalapril (Enalapril); Digoxin; Prednisone TAB



Adverse event in 65 year old male receiving Eryc (Erythromycin)

Reported by a physician from United States on 2007-06-20

Patient: 65 year old male

Adverse reactions / side effects: Rhabdomyolysis, Drug Level Increased, Drug Interaction

Adverse event resulted in: hospitalization

Suspect drug(s):
Eryc
    Dosage: oral
    Administration route: Oral
    Indication: Pneumonia

Lovastatin
    Dosage: 20 mg, tid, oral
    Administration route: Oral
    Indication: Blood Cholesterol Increased

Other drugs received by patient: Aspirin



Adverse event in 83 year old male receiving Eryc (Erythromycin)

Reported by a physician from Norway on 2007-06-11

Patient: 83 year old male, weighing 102.0 kg (224.4 pounds)

Adverse reactions / side effects: Weight Decreased, Bedridden, Respiratory Disorder, Creatinine Renal Clearance Decreased, Rhabdomyolysis

Adverse event resulted in: hospitalization

Suspect drug(s):
Eryc
    Dosage: 500 mg, qid, oral
    Administration route: Oral
    Indication: Pneumonia Primary Atypical

Erythromycin
    Dosage: 500 mg, qid, intravenous
    Indication: Pneumonia Primary Atypical

Simvastatin
    Dosage: 80 mg, qd

Other drugs received by patient: Metoprolol Tartrate; Amlodipine; Hydrochlorothiazide W / Valsartan (Hydrochlorothiazixe, Valsartan); Aspirin; Methotrexate; Furosemide



Adverse event in receiving Eryc (Erythromycin)

Reported by a individual with unspecified qualification from France on 2007-03-26

Patient:

Adverse reactions / side effects: Hypoacusis, Tinnitus, Deafness

Suspect drug(s):
Eryc (Erythromycin)

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009